Congress trades in Revance Therapeutics (RVNC)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Revance Therapeutics (RVNC) since 2023: 1 buy and 0 sales. The most recent was disclosed on Nov 2, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 1 / 0
- Reported value
- $1K–$15K
Who traded RVNC
MemberBuysSalesLast disclosed
- Sen. Thomas R. Carper (D-DE)1 buy · 0 sales10Nov 2, 2023
All trades
DisclosedTradeAmount
- Nov 2, 2023$1K–$15K
Sen. Thomas R. Carper (D-DE)
Bought Revance Therapeutics RVNC
$1K–$15K · Traded Oct 4, 2023 · disclosed Nov 2, 2023 · Spouse
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.